William D Gerull1, Daniel Cho2, Iris Kuo3, Saeed Arefanian4, Bradley S Kushner3, Michael M Awad3. 1. Department of Surgery, Section of Minimally Invasive Surgery, Washington University School of Medicine, St Louis, MO. Electronic address: wgerull@wustl.edu. 2. Dartmouth College, Hanover, NH. 3. Department of Surgery, Section of Minimally Invasive Surgery, Washington University School of Medicine, St Louis, MO. 4. Department of Surgery, University of Missouri, Columbia, MO.
Abstract
BACKGROUND: Little is known regarding important long-term outcomes after robotic paraesophageal hernia (PEH) repairs, such as symptom relief and recurrence rates. The aim of this study was to evaluate the long-term clinical outcomes in a large series of patients undergoing robotic PEH repair. STUDY DESIGN: This prospective, IRB-approved study analyzed adult patients who underwent robotic PEH repair, from 2010 to 2014, at a high-volume tertiary academic medical center. Detailed information on patient characteristics, perioperative factors, and long-term patient-reported outcomes for up to 5 years postoperatively were collected. Objective long-term outcomes included radiographic evidence of PEH recurrence at 1, 3, and 5 years postoperatively. RESULTS: A total of 233 patients underwent robotic PEH repair during the study period-70% were primary, 30% were revisional. Seventy-eight percent of patients (181) had a type III PEH, 21% (49) had a type IV, and 1% (3) had a type II. At 5 years postoperatively, 62% of patients (145 of 233) were available for follow-up, with a radiographic recurrence rate of 9% (13 of 145). Additionally, there was a significant improvement in the GERD-HRQL score at 5 years postoperatively (preoperative: 25.6 ± 8.7, 5-year postoperative, 4.5 ± 1.7, p < 0.01, 95% CI 19.7 to 22.5). CONCLUSIONS: This study represents one of the largest longitudinal robotic foregut surgical databases to date. Our results demonstrate that robotic PEH repair with an experienced surgical team is a safe and effective alternative to laparoscopic repair, with excellent long-term outcomes, including a very low recurrence rate.
BACKGROUND: Little is known regarding important long-term outcomes after robotic paraesophageal hernia (PEH) repairs, such as symptom relief and recurrence rates. The aim of this study was to evaluate the long-term clinical outcomes in a large series of patients undergoing robotic PEH repair. STUDY DESIGN: This prospective, IRB-approved study analyzed adult patients who underwent robotic PEH repair, from 2010 to 2014, at a high-volume tertiary academic medical center. Detailed information on patient characteristics, perioperative factors, and long-term patient-reported outcomes for up to 5 years postoperatively were collected. Objective long-term outcomes included radiographic evidence of PEH recurrence at 1, 3, and 5 years postoperatively. RESULTS: A total of 233 patients underwent robotic PEH repair during the study period-70% were primary, 30% were revisional. Seventy-eight percent of patients (181) had a type III PEH, 21% (49) had a type IV, and 1% (3) had a type II. At 5 years postoperatively, 62% of patients (145 of 233) were available for follow-up, with a radiographic recurrence rate of 9% (13 of 145). Additionally, there was a significant improvement in the GERD-HRQL score at 5 years postoperatively (preoperative: 25.6 ± 8.7, 5-year postoperative, 4.5 ± 1.7, p < 0.01, 95% CI 19.7 to 22.5). CONCLUSIONS: This study represents one of the largest longitudinal robotic foregut surgical databases to date. Our results demonstrate that robotic PEH repair with an experienced surgical team is a safe and effective alternative to laparoscopic repair, with excellent long-term outcomes, including a very low recurrence rate.
Authors: Dorcas Opoku; Alexander Hart; Dakota T Thompson; Catherine G Tran; Mohammed O Suraju; Jeremy Chang; Sonja Boatman; Alexander Troester; Paolo Goffredo; Imran Hassan Journal: Surg Open Sci Date: 2022-05-20
Authors: Sujay Kulshrestha; Haroon M Janjua; Corinne Bunn; Michael Rogers; Christopher DuCoin; Zaid M Abdelsattar; Fred A Luchette; Paul C Kuo; Marshall S Baker Journal: J Am Coll Surg Date: 2021-05-17 Impact factor: 6.532